Acquired did an episode on Novo Nordisk!

glp1guide — Thu, 25 Jan 2024 13:50:17 +0000

The Acquired Podcast, one of the best business deep-dive podcasts out there just did an article on Novo Nordisk, the company behind Semaglutide (i.e. Ozempic, Wegovy, etc).

The podcast is awesome, and it's a great deep dive into the over 100 years of innovation coming out of Denmark.

With the recent wave of GLP1 Receptor Agonists gaining popularity, it's great to learn more about the company and their history.

This was originally posted on GLP1.guide

My new year's resolution? Losing weight and learning more about GLP1

glp1guide — Wed, 10 Jan 2024 04:27:03 +0000

A lot of big things that happened in 2023 started with "G" -- well OK there was GPT and there's GLP1.

To hit my new years resolution I've been doing some research and trying to figure out how the "new" (and well researched) weight loss drugs that are all over the news works.

Digging into the papers

I put all my learnings into a single post which I'll summarize here:

Here's the simple version you could have looked up on Wikipedia:
The Term "GLP1 Agonist" refers to a class of drugs that reduce blood sugar and energy intake by activating the GLP1-receptor. (Wikipedia)

Let's make things even simpler:
Drugs that are called "GLP1 Agonist"s release a hormone in your stomach which is normally released after you eat. This calms your food cravings and makes it easy to eat less.

One of the best things about GLP1 Receptor Agonists is that there is a ton of research (a bunch funded by the firms that produce the peptides), so there's a lot to read up on.

Super excited to learn more about this stuff in 2024 -- as someone who has struggled with my weight in the past, it really seems like a game changer!

DEV Community: glp1guide

Acquired did an episode on Novo Nordisk!

My new year's resolution? Losing weight and learning more about GLP1